DISCOUNT ZERTIFIKAT - VERTEX PHARMACEUTICALS | Real-time Bid/Ask 09:25:49 29/05/2024 BST | ||
| 318.45 EUR / 319.86 EUR | +0.35% |
|
| Current month | +0.21% | ||
| 1 month | +0.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 318 | -0.15% |
| 27/05/24 | 318.5 | -0.05% |
| 24/05/24 | 318.7 | -0.34% |
| 23/05/24 | 319.8 | +0.29% |
| 22/05/24 | 318.9 | +0.23% |
Delayed Quote Börse Stuttgart
Last update May 28, 2024 at 09:47 am
More quotesStatic data
| Product type | Certificats Discount |
|---|---|
| Buy / Sell | CALL |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | ME7D8P |
| ISIN | DE000ME7D8P2 |
| Date issued | 23/01/2024 |
| Cap | 350 $ |
| Last trading day | 20/09/2024 |
| Maturity | 20/09/2024 (115 Days) |
| Parity | 1 : 1 |
| Emission price | 309.3 € |
| Emission volume | N/A |
| Payment day | 27/09/2024 |
| Bonus | - € |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Discount (ask) | 22.47 % |
|---|---|
| Sideways yield | 1.202 % |
| Sideways yield pa | 3.850 % |
| Outperformance point | 451.4 $ |
| Break even | 344.09 € |
| Highest since issue | 319.8 € |
| Lowest since issue | 303.4 € |
| Spread | 1.16 € |
| Spread % | 0.36% |
| Distance Cap | 96.88 $ |
| Distance Cap % | +21.68% |
| Max. earning | 3.837 |
| Max. earning % | 1.202 % |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
446.9
USD
Average target price
462.8
USD
Spread / Average Target
+3.57%
- Stock Market
- Certificates
- Certificat
